Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control
- PMID: 4089476
Suramin in the treatment of onchocerciasis: the efficacy of low doses on the parasite in an area with vector control
Abstract
In a village hyperendemic for onchocerciasis in Burkina Faso, where the vector had been controlled by the Onchocerciasis Control Programme since 1976, 65 patients were treated with doses of 37 to 71 mg/kg suramin in 1979. The viability and fertility of the adult parasites were studied in 217 nodules excised from 42 patients one month to four years after treatment using the collagenase technique. Most of the worms had survived the treatment. Male worms were more susceptible to suramin than female worms. The development of intrauterine stages initially continued, but was completely suppressed after several months. The female worms remained sterile in those patients who had received more than 60 mg/kg suramin. In other ones 11 and 13% of the female worms showed new embryonic stages in the uteri during two follow-up examinations in the second year. In a final examination in 1983 the reproduction had declined again. However, the reproductivity of the superannuated worms had considerably decreased in the untreated patients as well. All patients had shown a very high microfilardermia in 1979. After treatment the microfilarial densities dropped to levels near zero depending on the dose of suramin administered, but in none of the patients was the reduction complete during the first year of the treatment. Microfilariae gradually reappeared in the second year in several patients who had received less than 60 mg/kg suramin. In the final follow-up in 1983 most of the treated patients had become negative in skin counts, although they still harboured viable worms.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Evaluation of suramin, ivermectin and CGP 20376 in a new macrofilaricidal drug screen, Onchocerca ochengi in African cattle.Trop Med Parasitol. 1995 Mar;46(1):31-7. Trop Med Parasitol. 1995. PMID: 7631125 Clinical Trial.
-
Suramin and the time it takes to kill Onchocerca volvulus.Trop Med Parasitol. 1991 Dec;42(4):346-50. Trop Med Parasitol. 1991. PMID: 1796231
-
The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.Trop Med Parasitol. 1989 Sep;40(3):361-6. Trop Med Parasitol. 1989. PMID: 2694315 Clinical Trial.
-
The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects.Trop Med Parasitol. 1988 Dec;39 Suppl 4:423-40. Trop Med Parasitol. 1988. PMID: 2852394 Review.
-
Onchocerciasis.Br Med Bull. 1972 Jan;28(1):66-71. doi: 10.1093/oxfordjournals.bmb.a070896. Br Med Bull. 1972. PMID: 4562683 Review. No abstract available.
Cited by
-
The effects of Suramin on Ca2+ activated force and sarcoplasmic reticulum Ca2+ release in skinned fast-twitch skeletal muscle fibers of the rat.Physiol Rep. 2017 Jul;5(14):e13333. doi: 10.14814/phy2.13333. Physiol Rep. 2017. PMID: 28743820 Free PMC article.
-
Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions.Commun Biol. 2023 Apr 8;6(1):387. doi: 10.1038/s42003-023-04789-z. Commun Biol. 2023. PMID: 37031303 Free PMC article.